Cibles Therapeutiques, Institut National de la Santé et de la Recherche Médicale U940, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 75010 Paris, France.
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11572-7. doi: 10.1073/pnas.1104104108. Epub 2011 Jun 27.
The MHC class I antigen presentation pathway allows the immune system to distinguish between self and nonself. Despite extensive research on the processing of antigenic peptides, little is known about their origin. Here, we show that mRNAs carrying premature stop codons that prevent the production of full-length proteins via the nonsense-mediated decay pathway still produce a majority of peptide substrates for the MHC class I pathway by a noncanonical mRNA translation process. Blocking the interaction of the translation initiation factor eIF4E with the cap structure suppresses the synthesis of full-length proteins but has only a limited effect on the production of antigenic peptides. These results reveal an essential cell biological function for a class of translation products derived during the pioneer round of mRNA translation and will have important implications for understanding how the immune system detects cells harboring pathogens and generates tolerance.
MHC I 类抗原呈递途径使免疫系统能够区分自我和非自我。尽管对抗原肽的加工进行了广泛的研究,但对其来源知之甚少。在这里,我们表明,带有终止密码子的 mRNA 尽管通过无意义介导的衰变途径阻止全长蛋白的产生,但仍通过非典型的 mRNA 翻译过程产生大多数 MHC I 途径的肽底物。阻断翻译起始因子 eIF4E 与帽结构的相互作用会抑制全长蛋白的合成,但对抗原肽的产生只有有限的影响。这些结果揭示了在 mRNA 翻译的初始阶段产生的一类翻译产物的重要细胞生物学功能,对于理解免疫系统如何检测携带病原体的细胞并产生耐受具有重要意义。